S. Vignati
- Oncology top 5%
- Cancer-related Molecular Pathways 4
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 6
- Cancer, Hypoxia, and Metabolism 2
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Molecular Biology top 10%
- Angiogenesis and VEGF in Cancer 7
- RNA modifications and cancer 3
- TGF-β signaling in diseases 2
-
- Thyroid Cancer Diagnosis and Treatment 3
S. Vignati
22 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 79
- Oncology 793
- Cancer Research 388
- Pulmonary and Respiratory Medicine 569
- Hepatology 113
- Molecular Biology 879
Countries citing papers authored by S. Vignati
This map shows the geographic impact of S. Vignati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Vignati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Vignati more than expected).
Fields of papers citing papers by S. Vignati
This network shows the impact of papers produced by S. Vignati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Vignati. The network helps show where S. Vignati may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S. Vignati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 14 | |
| 2 | 2002 | 8 | |
| 3 | 1998 | 84 | |
| 4 | Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival. | 1998 | 262 |
| 5 | 67-Kilodalton laminin receptor expression correlates with worse prognostic indicators in non-small cell lung carcinomas. | 1997 | 37 |
| 6 | 1997 | 241 | |
| 7 | 1997 | 105 | |
| 8 | Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. | 1997 | 266 |
| 9 | 1997 | 11 | |
| 10 | 1996 | 76 | |
| 11 | Recurrence and death in non-small cell lung carcinomas: a prognostic model using pathological parameters, microvessel count, and gene protein products. | 1996 | 24 |
| 12 | Microvessel count: an indicator of poor outcome in medullary thyroid carcinoma but not in other types of thyroid carcinoma. | 1996 | 45 |
| 13 | 1995 | 172 | |
| 14 | 1995 | 110 | |
| 15 | 1994 | 25 | |
| 16 | 1994 | 3 | |
| 17 | 1994 | 2 | |
| 18 | [Post-operative examination of 2930 thyroid glands: observations on primary carcinoma. Incidental carcinoma and the preoperative diagnostic assessment of thyroidectomy for cancer]. | 1994 | 6 |
| 19 | 1994 | 1 | |
| 20 | [Chronic calculous cholecystitis: elementary and dysplastic lesions, echographic correlations and immunohistochemical approach]. | 1992 | 2 |
About S. Vignati
S. Vignati is a scholar working on Cancer Research, Hepatology, Equine, Oncology and Periodontics, having authored 22 papers that have together received 1.6k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (7 papers), Cancer, Lipids, and Metabolism (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer-related Molecular Pathways (4 papers), RNA modifications and cancer (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and TGF-β signaling in diseases (2 papers). The work is most often cited by research in Oncology (793 citations), Cancer Research (388 citations), Pulmonary and Respiratory Medicine (569 citations), Hepatology (113 citations) and Molecular Biology (879 citations). S. Vignati has collaborated with scholars based in Italy, United Kingdom and Belgium. Frequent co-authors include Gabriella Fontanini, Generoso Bevilacqua, A Mussi, Marco Lucchi, Fulvio Basolo, Carlo Alberto Angeletti, S Chinè, Vanesa L. Silvestri, C. A. Angeletti and Laura Boldrini. Their work appears in journals such as British Journal of Cancer, Lung Cancer, European Journal of Cancer, International Journal of Oncology and Veterinary Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.